318 results on '"Incorvaia L."'
Search Results
2. An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study
3. Future perspectives
4. Liquid biopsy and immunotherapy: is all that glitter gold?
5. Liquid biopsy: a right tool in a right context?
6. List of contributors
7. Current clinically validated applications of liquid biopsy
8. Molecular tumor board
9. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
10. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
11. Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
12. The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies
13. Liquid Biopsy in Esophageal, Gastric, and Pancreatic Cancers
14. Liquid Biopsy in Gynecological Cancers
15. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
16. Prospective On-Treatment Dynamics of Circulating Extracellular Vesicles in the First-Line Setting of Patients With Advanced Non-small Cell Lung Cancer
17. 42P Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation
18. 69P Trabectedin rechallenge for the treatment of adults with advanced soft tissue sarcoma (STS): A pilot study (Re-Trabe)
19. 1094P The clinical potential of circulating-free DNA (cfDNA) for real-time longitudinally monitoring clinical outcomes in a real-world first-line non-small cell lung cancer (NSCLC) prospective study
20. EP16.01-013 The Diagnostic Accuracy of Tumor Mutational Burden in Advanced NSCLC: An Individual Patient Data Meta-Analysis
21. 904MO Anthracycline-related cardiotoxicity in breast cancer patients carrying mutational signature of homologous recombination deficiency (HRD)
22. 49P Prognostic relevance of baseline exosome-delivered PD-1, PD-L1, pan-BTN3As and BTN3A1 in advanced cholangiocarcinoma patients: Can immune checkpoints act as a sentinel for predicting survival?
23. 208P Role of plasma exosomes in crosstalk between immune system and hereditary ovarian cancer: Opportunity or challenge?
24. 1655P Association of location of BRCA1/2 pathogenic variants with benefit from PARP-inhibitors in metastatic castration-resistant prostate cancers: Results from the PROGRESS study
25. 1582P Pregnancy and miscarriage in epithelial ovarian cancer (EOC) patients harboring mutational signature of homologous recombination deficiency (HRD)
26. P-264 The molecular-metabolic interplay in metastatic gastrointestinal stromal tumors (GISTs): The predictive role of body mass index
27. P-173 Understanding the treatment algorithm of patients with advanced G2 gastroenteropancreatic neuroendocrine neoplasms: A single-institution retrospective analysis
28. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
29. [From evidence to care sustainability: risk management by contrast agent in cancer patient. Experience in an italian teaching hospital]
30. Get up, stand up: Alongside adolescents and young adults with cancer for their right to be forgotten
31. C47 - Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin
32. 32P Can circulating immune checkpoints and KIT exon 11 mutations be prognostic factors in metastatic gastrointestinal stromal tumors?
33. 162P Prevalence and spectrum analysis of germline BRCA1 and BRCA2 variants of unclear significance in HBOC Syndrome: Decoding the mysterious signals of the genome
34. 1818P Body mass index (BMI) is not a cancer risk factor for BRCA1/2 carriers: A systematic review and meta-analysis of case-control studies
35. 1543P Gemcitabine in classic Kaposi’s sarcoma: A pilot study
36. 166P Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes
37. 167P Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
38. 1535P Exploring the dynamic crosstalk between immune system and genetics in a cohort of 116 completely resected gastrointestinal stromal tumors (GISTs)
39. 1974P Improved risk stratification with a prognostic nomogram incorporating the KIT-Variant Allele Frequency (VAF) and the 557/558 deletions: Results from a multi-institutional study in a cohort of intermediate-risk GIST patients
40. 1221P The functional domain of BRCA1/2 pathogenic variants (PVs) as potential biomarkers of second tumor and domain-related sensitivity to PARP-inhibitors
41. Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3)
42. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
43. 247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346 patients from Southern Italy (Sicily): When historical background affects genetics
44. 738P Soluble PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTN2A1 as predictive biomarkers of nivolumab response in patients with metastatic clear cell renal carcinoma
45. 1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lung cancer (NSCLC): A systematic review and meta-analysis of randomized controlled trials
46. Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features
47. Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives
48. Liquid Biopsy in Gastrointestinal Stromal Tumor
49. Safety of high doses of somatostatin analogs in well differentiated NENs in elderly
50. Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As and BTN3A1 in patients with metastatic gastrointestinal stromal tumours (mGISTs)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.